Contraceptives Market To Reach $30.86 Billion By 2022: Grand View Research, Inc.
Global contraceptives market is expected to reach USD
30.86 million by 2022, according to a new study by Grand View Research Inc.
Growing prevalence of sexually transmitted infections (STIs), especially HIV
and the introduction of new products exhibiting improved efficacy are expected
to drive the contraceptives market over the forecast period. The presence of
high unmet contraceptive needs coupled with the implementation of favorable
government policies is expected to significantly contribute towards the growth
of the contraceptives industry.
Global contraceptives market, by product, 2012 - 2022 (USD Billion) |
In
2014, contraceptives device was the largest product segment with revenue
estimated at over USD 12.0 billion. Devices such as condoms and contraceptive
sponges, which are relatively inexpensive and easy to use, are expected to
spearhead market growth over the forecast period. Female condoms are also
expected to gain penetration rates over the next seven years. Growing user
awareness levels and improving product availability are two key factors
expected to drive segment growth.
Browse full
research report on Contraceptives Market: www.grandviewresearch.com/industry-analysis/contraceptives-market
Further
Key findings from the study suggest:
- Condoms are identified as the most lucrative
sub segment of the contraceptive devices market. Low prices and abundant
product availability are two key factors expected to drive the condoms
market over the forecast period. The fact that, condoms are effective in preventing
sexually transmitted diseases and unwanted pregnancies is also expected to
boost usage rates.
- Intrauterine devices, especially hormonal IUDs
are expected to experience attractive growth over the forecast period.
Growing demand for Mirena, Jaydess and Skyla and the commercialization of
Liletta is expected to further drive segment growth.
- The North American contraceptives market
accounted for the largest revenue share in 2014. Presence of sophisticated
healthcare infrastructure, high user awareness levels and abundant product
availability are key factors attributing to the region’s market position.
- Latin America is expected to spearhead future
market growth. Numerous government programs and free distribution of
samples within the region are expected to help manufacturers capitalize on
the available opportunities.
- Asia Pacific is also expected to witness
substantial growth during the forecast period owing to, rapidly rising
population levels and the consequent rise in demand for contraception.
Presence of government initiatives in countries such as India, China, Sri
Lanka, Pakistan, and Bangladesh aimed at slowing down population growth
and prevalence of STDs are expected to promote market growth.
- Key players of the contraceptives market
include Reckitt Benckiser Plc, Mayer Laboratories, Actavis Plc, Church
& Dwight, Pfizer Inc., Merck & Co., The Female Health Company and
Teva Pharmaceuticals.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the contraceptives market on the basis
of products:
Global
Contraceptives Product Outlook (Revenue, USD Million, 2012 - 2022)
- Contraceptive
Drugs
- Contraceptive
Pills
- Topical
- Injectables
- Contraceptive
Devices
- Male
Condoms
- Female
Condoms
- Vaginal
Implants
- Subdermal
Implants
- Diaphragms
- Sponges
- IUDs
- Copper
IUD
- Hormonal
IUD
Contraceptives
Regional Outlook (Revenue, USD Million, 2012 - 2022)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- India
- Rest of
Asia Pacific
- Latin
America
- Brazil
- Rest of
Latin America
- Middle
East and Africa
- South
Africa
- Rest of
Middle East and Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-contraceptives-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business decisions, we
offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and
healthcare.
Comments
Post a Comment